Sun Pharmaceutical Industries Limited reported an inspiring 286.1% surge in net profit to Rs 1,241.1 crore for the Q3FY 2018-19 The Company, in the same period last year, had posted a net profit of Rs 321.5 crore. Operational revenues rose Read more
India’s second largest drug manufacturer Aurobindo Pharma Limited saw it net profit rose to Rs. 712.2 crore for the third quarter ended December 2018 as compared to Rs. 595 crore it had reported during the corresponding period previous fiscal. The Read more
Shares of Sun Pharmaceuticals Limited plunged over 10 percent in the morning deals on NSE and BSE on Monday,
The BSE Sensex plunged 806.47 points to 35,169.16 and the NSE Nifty shed 259 points to 10,599.30 on Thursday, on the back of falling rupee, rising crude prices and negative global cues.
ICICI Bank, Bharti Infratel, Ultratech Cement, Axis bank and L&T were among major gainers, while HPCL, BPCL, IOC, ONGC, Reliance lost the most.
Heavy selling pressure emerged across all the sectors. Nifty Bank index is trading at 26,832.60 down 1.22 percent. Nifty Pharma index was also trading down 0.07 percent on the NSE sectorally. Shares of Piramal Enterprises, Sun Phara, Lupin, Glenmark were top index losers.
Among sectoral watch, Nifty Realty went up 3.46% with Prestige Estates gained 9.93%, Indiabulls Real Estate added 5.57%, Phoenix Mills up 5.12% and Oberoi Realty rose 5.09% as top constituents. Further, Nifty Commodities added 2.55% while Nifty Pharma gained 2.51% on the weekend. Trading Call for 17-September.